Soybeans inhibit mammary tumors in models of breast cancer

scientific article published on 01 January 1990

Soybeans inhibit mammary tumors in models of breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2217394

P2093author name stringCarlson J
Setchell KD
Barnes S
Grubbs C
P921main subjectbreast cancerQ128581
P304page(s)239-253
P577publication date1990-01-01
P1433published inProgress in Clinical and Biological ResearchQ26842355
P1476titleSoybeans inhibit mammary tumors in models of breast cancer
P478volume347

Reverse relations

cites work (P2860)
Q37164347A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition
Q72030104A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids
Q44908026Analysis of isoflavone contents in vegetable soybeans
Q51788593Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats.
Q36089800Development of estimation methods of skin oxidation and evaluation of anti-oxidative effects of genistein in topical formulations
Q36802805Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells
Q33889019Flavonoids and age-related disease: risk, benefits and critical windows
Q72013145Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice
Q42796358Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[α]anthracene-induced rat mammary tumor model
Q34941433Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays
Q28387066Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease
Q42944121Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol
Q38763988Mass spectrometric evidence for the modification of small molecules in a cobalt-60-irradiated rodent diet.
Q42440089Phenoxodiol, a novel isoflavone derivative, inhibits dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female Sprague–Dawley rats
Q35119194Phyto-oestrogens and osteoporosis: what is a safe dose?
Q34832063Phytoestrogens are partial estrogen agonists in the adult male mouse
Q34831826Phytoestrogens: epidemiology and a possible role in cancer protection
Q35335557Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk
Q36744585Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary
Q91892351Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
Q30837716Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells
Q24628910The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer
Q43199168The phytoestrogen content of rodent diets
Q28343395The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
Q44510436Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells

Search more.